 | Up a level |
Günther, G; Guglielmetti, L; Leu, C; van Leth, F; Lange, C (2023). Relative cost of multidrug-resistant TB medicines in Europe. The international journal of tuberculosis and lung disease, 27(5), pp. 341-344. IUATLD 10.5588/ijtld.23.0026
Günther, G; Saathoff, E; Rachow, A; Ekandjo, H; Diergaardt, A; Marais, N; Lange, C; Nepolo, E (2022). Clinical Evaluation of a Line-Probe Assay for Tuberculosis Detection and Drug-Resistance Prediction in Namibia. Microbiology spectrum, 10(3), e0025922. American Society for Microbiology 10.1128/spectrum.00259-22
Lange, C; Aarnoutse, R E; Alffenaar, J W C; Bothamley, G; Brinkmann, F; Costa, J; Chesov, D; van Crevel, R; Dedicoat, M; Dominguez, J; Duarte, R; Grobbel, H P; Günther, Gunar; Guglielmetti, L; Heyckendorf, J; Kay, A W; Kirakosyan, O; Kirk, O; Koczulla, R A; Kudriashov, G G; ... (2019). Management of patients with multidrug-resistant tuberculosis. The international journal of tuberculosis and lung disease, 23(6), pp. 645-662. IUATLD 10.5588/ijtld.18.0622
Eker, B; Ortmann, J; Migliori, GB; Sotgiu, G; Muetterlein, R; Centis, R; Hoffmann, H; Kirsten, D; Schaberg, T; Ruesch-Gerdes, S; Lange, C (2008). Multidrug- and extensively drug-resistant tuberculosis. Emerging infectious diseases, 11(14), pp. 1700-1706. Atlanta, Ga.: U.S. National Center for Infectious Diseases 10.3201/eid1411.080729
